Among them, the editing sites chr8:103841636 in AZIN1 (S367G) and chr4:2940026 in NOP14 (I779V), which were previously reported to have significantly elevated editing levels in lung adenocarcinoma from a pan-cancer analysis [19], were detected in two tumors and one tumor, respectively (Table 1). The gene discussed is NOP14; the disease is neoplasm.